CN104174013B - 一种含促肝细胞生长素的组合物和应用 - Google Patents
一种含促肝细胞生长素的组合物和应用 Download PDFInfo
- Publication number
- CN104174013B CN104174013B CN201410403950.9A CN201410403950A CN104174013B CN 104174013 B CN104174013 B CN 104174013B CN 201410403950 A CN201410403950 A CN 201410403950A CN 104174013 B CN104174013 B CN 104174013B
- Authority
- CN
- China
- Prior art keywords
- hepatocyte growth
- promoting factors
- parts
- acyclovir
- aspirin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003494 hepatocyte Anatomy 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 30
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960001138 acetylsalicylic acid Drugs 0.000 claims abstract description 16
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960004150 aciclovir Drugs 0.000 claims abstract description 16
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960000304 folic acid Drugs 0.000 claims abstract description 15
- 235000019152 folic acid Nutrition 0.000 claims abstract description 15
- 239000011724 folic acid Substances 0.000 claims abstract description 15
- 208000006454 hepatitis Diseases 0.000 abstract description 19
- 231100000283 hepatitis Toxicity 0.000 abstract description 19
- 239000003814 drug Substances 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 10
- 241000700159 Rattus Species 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 7
- 239000012980 RPMI-1640 medium Substances 0.000 description 6
- 239000003365 glass fiber Substances 0.000 description 6
- 230000000394 mitotic effect Effects 0.000 description 6
- 230000002980 postoperative effect Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 210000005161 hepatic lobe Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007928 intraperitoneal injection Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 3
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 241000700605 Viruses Species 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003834 purine nucleoside derivatives Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410403950.9A CN104174013B (zh) | 2014-08-16 | 2014-08-16 | 一种含促肝细胞生长素的组合物和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410403950.9A CN104174013B (zh) | 2014-08-16 | 2014-08-16 | 一种含促肝细胞生长素的组合物和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104174013A CN104174013A (zh) | 2014-12-03 |
CN104174013B true CN104174013B (zh) | 2015-07-08 |
Family
ID=51955541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410403950.9A Active CN104174013B (zh) | 2014-08-16 | 2014-08-16 | 一种含促肝细胞生长素的组合物和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104174013B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104587454A (zh) * | 2014-12-23 | 2015-05-06 | 李才锐 | 一种治疗病毒性肝炎的组合物及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1566154A (zh) * | 2003-07-07 | 2005-01-19 | 华北制药集团有限责任公司 | 一种新型促肝细胞生长因子、制备方法及其用途 |
CN101116670A (zh) * | 2006-08-01 | 2008-02-06 | 广州和竺生物科技有限公司 | 可提供活性甲基或参与甲基转移的化合物作为制备治疗病毒性疾病的药的应用 |
CN101225101A (zh) * | 2008-02-04 | 2008-07-23 | 杭州华锦药业有限公司 | 一种促肝细胞生长素溶液制备工艺 |
CN101560506A (zh) * | 2009-05-22 | 2009-10-21 | 江苏省江大绿康生物工程技术研究有限公司 | 一种以动物肝脏为原料同时制备过氧化氢酶和促肝细胞生长液的工艺 |
CN101720222A (zh) * | 2007-06-21 | 2010-06-02 | 学校法人城西大学 | 具有促进肝细胞增殖作用的药物 |
-
2014
- 2014-08-16 CN CN201410403950.9A patent/CN104174013B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1566154A (zh) * | 2003-07-07 | 2005-01-19 | 华北制药集团有限责任公司 | 一种新型促肝细胞生长因子、制备方法及其用途 |
CN101116670A (zh) * | 2006-08-01 | 2008-02-06 | 广州和竺生物科技有限公司 | 可提供活性甲基或参与甲基转移的化合物作为制备治疗病毒性疾病的药的应用 |
CN101720222A (zh) * | 2007-06-21 | 2010-06-02 | 学校法人城西大学 | 具有促进肝细胞增殖作用的药物 |
CN101225101A (zh) * | 2008-02-04 | 2008-07-23 | 杭州华锦药业有限公司 | 一种促肝细胞生长素溶液制备工艺 |
CN101560506A (zh) * | 2009-05-22 | 2009-10-21 | 江苏省江大绿康生物工程技术研究有限公司 | 一种以动物肝脏为原料同时制备过氧化氢酶和促肝细胞生长液的工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN104174013A (zh) | 2014-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2560058A1 (en) | A method for inhibiting cancer cell proliferation or increasing cancer cell apoptosis | |
CN105963637B (zh) | 隐丹参酮联合姜黄素在制备肿瘤治疗药物中的应用 | |
WO2014131213A1 (zh) | 表没食子儿茶素没食子酸酯的制备方法及其用途 | |
CN105456302A (zh) | 大黄酚或其衍生物和溶瘤病毒在制备抗肿瘤药物的应用 | |
CN114028453B (zh) | 广谱抗病毒药物、及其药物组合物和应用 | |
EP3391893A1 (en) | Medicine composition for treating leukemia and preparation method therefor | |
CN104174013B (zh) | 一种含促肝细胞生长素的组合物和应用 | |
CN106580979A (zh) | 吡啶杂环酯类化合物在制备抗柯萨奇病毒b3型的药物中的应用 | |
CN105796638B (zh) | 冬凌草甲素联合隐丹参酮在制备白血病治疗药物中的应用 | |
CN110882264A (zh) | 一种天麻素和甘露糖醛酸寡糖的药物组合物及其用途 | |
WO2010130147A1 (zh) | 乳酸咯萘啶及其药物组合物和用途 | |
CN103239488A (zh) | 虎舌红粗提取物的应用 | |
CN1141101C (zh) | 治疗乙肝的药物及其制备方法 | |
CN111973587B (zh) | 槲皮素在制备抗草鱼呼肠孤病毒药物中的用途 | |
CN1919339A (zh) | 含有蛋白的葫芦素纳米制剂及制备方法和用途 | |
CN112891341A (zh) | Gl-v9与蒽环类抗生素在制备白血病治疗药物中的应用 | |
CN112603920A (zh) | 一种中药川楝素在制备防治神经系统胶质瘤产品中的应用 | |
CN105125498A (zh) | 一种降血脂药物匹伐他汀钙组合物干混悬剂 | |
CN1850837A (zh) | 9-(1, 3-苯并二恶茂基-5)-4-(β-D-吡喃葡氧基)-6,7-二甲氧基萘并[2, 3-C]呋喃-1[3H] 酮, 其制备方法和含有该化合物的药物组合物 | |
CN1687033A (zh) | 一种抗呼吸道病毒的药物及用途 | |
CN107281177B (zh) | 促进造血干细胞归巢和植入的方法 | |
CN107259559B (zh) | 菜籽多肽与五味子水提物及协同改善睡眠的方法 | |
CN116019823B (zh) | 一种治疗儿童手足口病的药物组合物及其药物的应用 | |
CN104587454A (zh) | 一种治疗病毒性肝炎的组合物及其制备方法 | |
CN1279912C (zh) | 青藤碱新用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Composition containing hepatocyte growth-promoting factors and application thereof Effective date of registration: 20160108 Granted publication date: 20150708 Pledgee: Guangzhou branch directly under the China Co truction Bank Corp. Pledgor: Guangzhou Yipinhong Pharmaceutical Co.,Ltd. Registration number: 2016990000015 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20181122 Registration number: 2016990000015 Pledgee after: China Co. truction Bank Corp Guangzhou branch Pledgee before: Guangzhou branch directly under the China Co truction Bank Corp. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190109 Granted publication date: 20150708 Pledgee: China Co. truction Bank Corp Guangzhou branch Pledgor: Guangzhou Yipinhong Pharmaceutical Co.,Ltd. Registration number: 2016990000015 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Composition containing hepatocyte growth-promoting factors and application thereof Effective date of registration: 20190218 Granted publication date: 20150708 Pledgee: China Co. truction Bank Corp Guangzhou branch Pledgor: Guangzhou Yipinhong Pharmaceutical Co.,Ltd. Registration number: 2019440000069 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190426 Granted publication date: 20150708 Pledgee: China Co. truction Bank Corp Guangzhou branch Pledgor: Guangzhou Yipinhong Pharmaceutical Co.,Ltd. Registration number: 2019440000069 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221115 Address after: No.6 Dongbo Road, East District, Guangzhou Economic and Technological Development Zone, Guangdong 510000 Patentee after: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. Patentee after: GUANGDONG ZERUI PHARMACEUTICAL Co.,Ltd. Patentee after: Guangzhou Lianrui Pharmaceutical Co.,Ltd. Patentee after: Guangzhou Runlin Pharmaceutical Technology Co.,Ltd. Patentee after: Euphorbia Biological Medicine Co.,Ltd. Address before: Building 1, No. 6, Dongbo Road, Guangzhou Economic and Technological Development Zone, Guangzhou, Guangdong 510765 Patentee before: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |